TR201901012T4 - Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. - Google Patents

Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. Download PDF

Info

Publication number
TR201901012T4
TR201901012T4 TR2019/01012T TR201901012T TR201901012T4 TR 201901012 T4 TR201901012 T4 TR 201901012T4 TR 2019/01012 T TR2019/01012 T TR 2019/01012T TR 201901012 T TR201901012 T TR 201901012T TR 201901012 T4 TR201901012 T4 TR 201901012T4
Authority
TR
Turkey
Prior art keywords
arteriosclerosis
treatment
bile acids
esters
derivatives
Prior art date
Application number
TR2019/01012T
Other languages
English (en)
Inventor
Tarek Moustafa
Trauner Michael
Fickert Peter
Original Assignee
Univ Graz Medizinische
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Graz Medizinische filed Critical Univ Graz Medizinische
Publication of TR201901012T4 publication Critical patent/TR201901012T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Mevcut buluş, arterioskleroz tedavisinde nor-safra asitlerinin ve bunların farmasötik olarak kabul edilebilir tuzları, esterleri ve/veya türevlerinin kullanımı ile ilgilidir.
TR2019/01012T 2007-07-25 2008-07-24 Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. TR201901012T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95172807P 2007-07-25 2007-07-25
EP07113107 2007-07-25

Publications (1)

Publication Number Publication Date
TR201901012T4 true TR201901012T4 (tr) 2019-02-21

Family

ID=39744896

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/01012T TR201901012T4 (tr) 2007-07-25 2008-07-24 Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı.

Country Status (7)

Country Link
US (2) US20100311708A1 (tr)
EP (1) EP2182954B1 (tr)
ES (1) ES2709489T3 (tr)
PT (1) PT2182954T (tr)
SI (1) SI2182954T1 (tr)
TR (1) TR201901012T4 (tr)
WO (1) WO2009013334A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468762A1 (en) * 2010-11-30 2012-06-27 Dr. Falk Pharma Gmbh Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size
EP3461485A1 (en) * 2017-09-28 2019-04-03 Dr. Falk Pharma Gmbh Use of nor-ursodeoxycholic acid for reducing liver fat
WO2021130232A1 (en) 2019-12-23 2021-07-01 Medizinische Universität Wien Bile acid derivatives in the medical intervention of anxieties and/or stress symptoms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892868A (en) * 1984-08-17 1990-01-09 Gipharmex, S.P.A. Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions
IT1255449B (it) * 1992-06-30 1995-10-31 Fabio Berlati Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
TW289020B (tr) * 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
IL123998A (en) * 1998-04-08 2004-09-27 Galmed Int Ltd Conjugates of bile salts and pharmaceutical preparations containing them
IL142650A (en) * 1998-04-08 2007-06-03 Galmed Int Ltd Use of bile acid or bile salt fatty acids conjugates for the preparation of pharmaceutical compositions for reducing cholesterol, treating fatty liver and treating hyperglycemia and diabetes
US7312208B2 (en) * 2002-08-28 2007-12-25 Asahi Kasei Pharma Corporation Quaternary ammonium compounds
EP1890705B1 (en) * 2005-05-12 2015-11-11 Medizinische Universität Graz Use of 24-nor-UDCA for the treatment of cholestatic liver diseases
US20070116755A1 (en) * 2005-11-22 2007-05-24 Zadini Filiberto P Dissolution of arterial cholesterol plaques by pharmacological preparation

Also Published As

Publication number Publication date
US20100311708A1 (en) 2010-12-09
ES2709489T3 (es) 2019-04-16
WO2009013334A1 (en) 2009-01-29
EP2182954B1 (en) 2018-11-28
EP2182954A1 (en) 2010-05-12
SI2182954T1 (sl) 2019-04-30
US20200101084A1 (en) 2020-04-02
PT2182954T (pt) 2019-02-06

Similar Documents

Publication Publication Date Title
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
CN102036649A8 (zh) 精氨酸盐及其治疗口腔疾病的用途
CY1121646T1 (el) Παραγωγα μορφινανης για την αγωγη υπερβολικης δοσης ναρκωτικων
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
EP2220046A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220095A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220076A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EP2220084A4 (en) INHIBITORS OF THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
DE602007011902D1 (de) Spiroindolinon-derivate
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
UA109650C2 (xx) Біс-арилзв'язані арилтриазолони та їх застосування
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
MX2009010485A (es) Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas.
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
CY1117959T1 (el) 24-norudca για την αγωγη αυτοανοσης ηπατιτιδας
AR058098A1 (es) Derivados de acidos dicarboxilicos y su uso
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren
AR063027A1 (es) Derivados de sulfonamida
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
TW200833342A (en) 2-substituted pyrimidines I in therapy